8-K
Current Report
Ultragenyx Pharmaceutical Inc. Filed Acc 0000950170-22-012192
Shareholder vote results
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading rare-20220624.htm…